drugset / Trial / NCT00947037

Gastric Retentive Carbidopa/ Levodopa in Parkinson's Patients; a One Year, Open Label, Safety Extension Study

NCT00947037 ↗

Phase 2 Withdrawn Intec Pharma Ltd.
NaSingle-groupOpen-labelTreatment

Summary

An extension of study IN 09 004 testing the long term safety of the Accordion Pill Carbidopa/Levodopa (AP-CD/LD)

Timeline

Start
2012-08
Primary completion
2012-08
Completion
—

Outcome

Outcome not reported

Stopped: “The sponsor decided to postpone the performance of this study to after phase 3”

Drugs

EvaluationDrugModalityDoseRoute
Subject Carbidopa Unknown — —
Subject Levodopa Unknown — —

Indications